Overcoming TGFβ-mediated immune evasion in cancer

DVF Tauriello, E Sancho, E Batlle - Nature Reviews Cancer, 2022 - nature.com
Transforming growth factor-β (TGFβ) signalling controls multiple cell fate decisions during
development and tissue homeostasis; hence, dysregulation of this pathway can drive …

TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis

Y Hao, D Baker, P Ten Dijke - International journal of molecular sciences, 2019 - mdpi.com
Transforming growth factor β (TGF-β) is a secreted cytokine that regulates cell proliferation,
migration, and the differentiation of a plethora of different cell types. Consistent with these …

Lymphatic migration of immune cells

HR Hampton, T Chtanova - Frontiers in immunology, 2019 - frontiersin.org
Lymphatic vessels collect interstitial fluid that has extravasated from blood vessels and
return it to the circulatory system. Another important function of the lymphatic network is to …

Regulation of innate and adaptive immunity by TGFβ

A Kelly, SA Houston, E Sherwood, J Casulli… - Advances in …, 2017 - Elsevier
Immune regulation by cytokines is crucial in maintaining immune homeostasis, promoting
responses to infection, resolving inflammation, and promoting immunological memory …

Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles

MI Koukourakis, A Giatromanolaki - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The tumor-draining lymph nodes (TDLNs) are the primary sites of the development of anti-
tumor immunity. Primary tumor irradiation promotes 'radio-vaccination'by enhancing the …

Molecular mechanisms of dendritic cell migration in immunity and cancer

CM de Winde, C Munday, SE Acton - Medical microbiology and …, 2020 - Springer
Dendritic cells (DCs) are a heterogeneous population of antigen-presenting cells that act to
bridge innate and adaptive immunity. DCs are critical in mounting effective immune …

Nanovaccine loaded with poly I: C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo

Z Luo, C Wang, H Yi, P Li, H Pan, L Liu, L Cai, Y Ma - Biomaterials, 2015 - Elsevier
Although cancer vaccine-based immunotherapy holds great potential for cancer treatment,
tumor-induced dendritic cell (DC) dysfunction remains to be the major obstacle for …

DCision-making in tumors governs T cell anti-tumor immunity

F Alfei, PC Ho, WL Lo - Oncogene, 2021 - nature.com
The exploitation of T cell-based immunotherapies and immune checkpoint blockade for
cancer treatment has dramatically shifted oncological treatment paradigms and broadened …

The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective

Y Li, C Ayala-Orozco, PR Rauta, S Krishnan - Nanoscale, 2019 - pubs.rsc.org
Cancer immunotherapy is emerging as a promising treatment modality that suppresses and
eliminates tumors by re-activating and maintaining the tumor-immune cycle, and further …

The therapeutic potential of tackling tumor-induced dendritic cell dysfunction in colorectal cancer

B Subtil, A Cambi, DVF Tauriello… - Frontiers in …, 2021 - frontiersin.org
Colorectal cancer (CRC) is the third most diagnosed malignancy and the second leading
cause of cancer-related deaths worldwide. Locally advanced and metastatic disease exhibit …